NextEra Partners powers higher as Morgan Stanley double upgrades
NextEra Energy Partners (NYSE:NEP) +13.6% in Monday's trading after Morgan Stanley double upgrades the clean energy company to Overweight from Underweight with a $22 price target, saying the stock has overly discounted negative outcomes of its ongoing strategic review.
Okta upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley upgraded Okta (OKTA) to Overweight from Equal Weight with a price target of $97, up from $92. The firm says that while positive
Morgan Stanley Upgrades Zebra Technologies (ZBRA)
Fintel reports that on December 2, 2024, Morgan Stanley upgraded their outlook for Zebra Technologies (NasdaqGS:ZBRA) from Underweight to Equal-Weight. Analyst Price Forecast Suggests 2.49% Upside As of November 21,
Zebra upgraded on improving market demand: Morgan Stanley
Zebra Technologies (NASDAQ:ZBRA) was upgraded to Equal-Weight from Underweight by Morgan Stanley due to improving market demand over the next twelve months and a growing customer base. The price target was also increased by more than 30% to $400 from $305.
Intuitive Surgical assumed at Overweight from Equal Weight at Morgan Stanley
Morgan Stanley upgraded Intuitive Surgical (ISRG) to Overweight from Equal Weight with a price target of $650, up from $522, as the analyst
Morgan Stanley upgrades Zebra Tech on improved demand outlook
Morgan Stanley has upgraded Zebra Technologies Corporation (NASDAQ:ZBRA) to “equal weight” from “underweight” on healthier consumer data, improving retail capital expenditures, and de-risked 2025 estimates.
How Job Cuts, Language Barriers And Tech Inefficiencies Led To Morgan Stanley’s Failure To Vet Ultra-Wealthy Clients
A recent investigation uncovered significant regulatory deficiencies within Morgan Stanley's wealth management operations.
CAVA to Participate in Morgan Stanley Global Consumer and Retail Conference
CAVA Group, Inc. (NYSE: CAVA), the category-defining Mediterranean fast-casual restaurant brand that brings heart, health, ...
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.
InvestmentNews6d
Morgan Stanley courted AML risks as it wooed wealthy clients, says WSJ report
Amid its aggressive global push, lax procedures at the firm led to one-fourth of international accounts being flagged as high ...
How Morgan Stanley Courted Dodgy Customers to Build a Wealth-Management Empire
Internal company documents describe the bank’s weak anti-money-laundering controls and failure to complete due-diligence ...
Morgan Stanley to Sell NYC Park Avenue Office Condo to SL Green
SL Green Realty Corp. is in contract to purchase the office portion of Manhattan’s 500 Park Ave., the former headquarters of ...
Why Is DoorDash, Inc. (DASH) Among the Best Cyclical Stocks for Economic Recovery According to Morgan Stanley?
We recently compiled a list of the Morgan Stanley’s Best Stocks For Economic Recovery: Top 9 Cyclical Stocks. In this article ...
Sportradar to Participate in the Morgan Stanley Consumer & Retail Conference
Sportradar Group AG (NASDAQ: SRAD) (“Sportradar” or the “Company”), a leading global sports technology company focused on creating immersive experiences for sports fans and bettors, today announced ...
Leaked Morgan Stanley documents reveal 1 in 4 ultrawealthy clients raise a red flag
A whopping 24% of Morgan Stanley international wealth-management accounts were labeled by the company as being high risk for ...